http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180121060-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4ad61d0af1fd483d31d1c5df9b9b76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4808 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4825 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate | 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edaa4ea9eab2c847f3bba23af0b856d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90c86124fa98ebe82bd4b114219d5514 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f7b5826093f27ab1c3ef54a17092a2d7 |
| publicationDate | 2018-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20180121060-A |
| titleOfInvention | Once-daily fixed-dose combination capsule formulations comprising sustained release cilostazol and immediate release statin minitablets and preparation method thereof |
| abstract | The present invention relates to a once-daily oral capsule preparation containing a fixed-dose cilostazol-releasing and statin-releasing mini-tablet, and a process for preparing the same, wherein the cilostazol-releasing mini-tablet comprises Certain fixed quantities of residual gum and ethylcellulose or Ethylcellulose and Eudragit RL or RS were used, statin general release mini tablets were prepared by high shear wet granulation method using immediate release additives and then filled into gelatin hard capsules to obtain fixed dose cilostazol and statin , It is possible to provide a composite capsule capable of oral administration once a day. Therefore, it is possible to provide a combination preparation for an elderly patient in which ischemic complex vascular disease accompanied by hyperlipidemia is frequent, and a combination preparation for patients suffering from diabetes, chronic cardiovascular disease and kidney disease It can be widely used, and the convenience of medication and patient compliance can be improved. |
| priorityDate | 2017-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.